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KAJIAN MEKANISME ANTI KANSER TERHADAP EKSTRAK     
Eupatorium odoratum L. DAN Euphorbia hirta L. 
 
ABSTRAK 
 
Eupatorium odoratum L. (EO) dan Euphorbia hirta L. (EH) merupakan dua 
tumbuhan yang acapkali digunakan dalam rawatan tradisional untuk menyembuhkan 
luka, asma dan ketumbuhan. Walaupun terdapat laporan aktiviti anti-kanser dari 
genus tumbuhan ini, hanya sedikit maklumat yang diketahui berkaitan perihal 
mekanisme anti kanser daripada spesies ini. Dalam kajian ini, keupayaan ekstrak EO 
dan EH untuk membunuh sel kanser diuji menggunakan sel kanser payudara (MCF-
7), kanser serviks (Hela), kanser ovari (CaOV-3) dan sel normal epithelial (Vero). 
Sel-sel kanser di rawat dengan ekstrak tumbuhan menggunakan sembilan kepekatan 
berbeza pada tiga tempoh masa yang berlainan (24, 48 72 jam) dan parameter berikut 
diperhatikan: (1) penentuan nilai IC50 dan kesan sitotoksik terhadap sel kanser 
melalui asai MTT dan perisian GraphPad Prism, (2) pemerhatian morfologi 
menggunakan mikroskop ‘inverted’ dan ‘fluorescent’, (3) kesan apoptosis menerusi 
kajian penanggaan DNA dan kadar pengekspresan protein (BCl-2 dan Bax), (4) 
kesan autofagi melalui pengekspresan BCl-2 dan LC3-A dan (5) kesan tehadap fasa 
kitaran sel menggunakan kaedah ‘flow cytometry’. Ekstrak etil asetat dari E. 
odoratum (EOea) menunjukkan kesan sitotoksik terhadap sel Hela, CaOV-3 dan 
MCF-7 pada nilai IC50 40-95 µg/ml. Manakala, ekstrak aseton E. odoratum (EOace) 
hanya menunjukkan kesan sitotoksik terhadap sel MCF-7. Ekstrak etil asetat 
daripada E. hirta merekodkan nilai IC50 dalam lingkungan 40-55 µg/ml. Ekstrak 
tumbuhan yang digunakan dalam kajian ini menunjukkan kesan sitotoksik yang 
lemah terhadap sel Vero yang digunakan sebagai sel kawalan normal. Pemerhatian 
xiii 
 
morfologi sel MCF-7 yang dirawat dengan EOace menunjukkan kesan khusus 
kematian autofagi, dan ini dipastikan dengan pengekspresan protein LC3-A yang 
terlibat dalam proses tersebut. Pemerhatian yang sama turut direkodkan bagi sel 
CaOV-3 yang dirawat menggunakan EOea. Walau bagaimanapun, kesan 
pengekspressan adalah lebih rendah. Maka mekanisme kematian sel melalui 
mekanisme autofagi tidak dapat dipastikan. Bagi sel Hela yang dirawat dengan EHea, 
kesan autofagi dapat dilihat pada permulaan rawatan (24 jam). Namun demikian, 
pada jam ke 48, pengecutan sel dan pemampatan nukleus diperhatikan. Pada akhir 
jam ke 72, hampir kesemua sel menunjukkan kesan penanggalan dari permukaan 
kultur. Ini mencadangkan kematian sel melalui apoptosis. Mekanisme apoptosis 
dikuatkan dengan kesan penanggaan DNA dan peningkatan dalam pengekspresan 
protein Bax pada jam ke 48 dan ke 72. Analisis fasa kitaran sel menunjukkan 
peningkatan populasi sel Hela yang dirawat dengan ektrak EHea pada fasa G0/G1. 
Selain itu, corak penurunan populasi sel dalam fasa S dapat dilihat dalam rawatan 
EOea terhadap sel CaOV-3. Manakala, ekstrak-ekstrak lain tidak menunjukkan kesan 
terhadap fasa kitaran sel. Hasil kajian ini turut menujukkan kesan ekstrak adalah unik 
terhadap sesuatu sel kanser. Ekstrak aseton dan metanol mengakibatkan penambahan 
populasi sel. Pemerhatian ini mencadangkan agar penggunaan ekstrak ini hendaklah 
mengambil kira kadar pemberian dos pada sesuatu masa agar kesan sitotoksik dapat 
dikekalkan. Secara keseluruhan, keputusan kajian mencetuskan andaian awal 
terhadap dua mekanisma kematian sel yang berlainan oleh ekstrak tumbuhan 
terhadap sel yang berasal dari kawasan berbeza dan kepentingan untuk mengekalkan 
kepekatan ekstrak pada sesuatu tahap tertentu bagi mengekalkan kesan sitotoksiti 
ekstrak.   
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MECHANISTIC STUDIES OF THE ANTICANCER ACTIVITY OF THE 
EXTRACTS OF Eupatorium odoratum L. AND Euphorbia hirta L. 
 
 
ABSTRACT 
 
Eupatorium odoratum L. (EO) and Euphorbia hirta L. (EH) are two plants which are 
commonly used traditionally to treat wounds, asthma, warts and tumors. Even though 
the anti-cancer properties were described previously in the species, little was known 
on the activity of these plants specifically and on mechanism of cell death induced by 
these plant extracts. Hence, in this study, the ability of the plant extract to induce cell 
death was evaluated. Human breast carcinoma (MCF-7), human cervical carcinoma 
(Hela), human ovarian carcinoma (CaOV-3) and Vero cells were evaluated for 
response to treatment with EO and EH extracts. The cells were treated with nine 
different concentrations of respective extracts at three different time intervals (24, 48 
and 72 hours) and assessed for the following parameters. (1) cell death using MTT 
assay and graph pad prism software to assess the cytotoxicity effects and IC50 values, 
(2) morphology of the cells using visible and fluorescent microscopy, (3) apoptosis 
using DNA ladder assay and expression of BCl-2 and Bax proteins as markers, (4) 
autophagy using BCl-2 and LC3-A protein expression as markers and (5) cell cycle 
effects using flow cytometry. Ethyl acetate extracts of E. odoratum (EOea) showed 
potent cytotoxicity against Hela, CaOV-3 and MCF-7 cells at IC50 values ranging 
from 40-95 µg/ml while EOace showed promising effects on MCF-7 cells only. 
Ethyl acetate extracts of E. hirta (EHea) showed effective cytotoxic effects on Hela 
and CaOV-3 cells with IC50 values in the range of 40-55 µg/ml. The extracts were 
non-toxic to Vero cells. Morphological observations on treatment with EOea and 
acetone extract (EOace), showed typical features of autophagic mechanism of cell 
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death in MCF-7 cells. This was confirmed by upregulated expression of LC3-A 
protein. This pattern was also observed with CaOV-3 cells even though at a lower 
degree. Lower expression of LC3-A and no DNA fragmentation were observed 
casting doubts over autophagy or apoptosis as the cell death mechanism. Hela cells 
treated with EHea showed initial autophagic signs with moderate LC3-A expression. 
At 24 hours, shrunken cells and nuclear condensation at 48 hours and detachment of 
the cells were seen by 72 hours suggesting apoptotic cell death. This was also 
supported by DNA ladder formation at 48 and 72 hours, reduced LC3-A protein 
expression and increased Bax protein expression at this time. Results of cell cycle 
analysis showed increase in G0/G1 cell population in Hela cells treated with EHea, 
trend towards S phase arrest in CaOV-3 cells treated with EOea, and cell cycle 
independent effects with other extracts. These results suggest the differential effects 
of the extracts on cell lines. The increased in IC50 values with time and observation 
of proliferative effects of the etracts at lower concentrations suggest the necessity of 
maintaining optimum bioavailable doses. However, this proliferation enhancing 
property can be made use of for formulation of wound healing agents. Thus, the 
observed results provide a description of the potential of the two plants evaluated in 
this study to induce cell death through different mechanisms in epithelial cells of 
different origin and also points to the need of maintaining required bioavailable 
doses when used for therapy. 
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CHAPTER 1 - INTRODUCTION 
 
Cancer of the breast, uterine cervix and ovary are the leading female cancers and 
their incidence is on the increase. This fact prompted us to evaluate the effect of the 
plant extracts on breast adenocarcinoma (MCF-7), ovarian cancer (CaOV-3) and 
cervical cancer (Hela) cell lines and compared it with the normal epithelial cells in 
this study.  
 
In spite of advances in treatment modalities such as surgery, radiotherapy, 
chemotherapy, and hormone therapy for the above cancers, the treatment response 
has not improved substantially. This calls for identification of novel effective 
chemotherapeutic agents which could have immense impact on the mortality and 
morbidity due to these cancers. The urge to seek for new chemotherapeutic drugs 
from plants is based on its application in traditional medicine to treat many kinds of 
disorders (Otsuki et al., 2010). As an example, native people in Africa, use upto 4000 
taxas of plant in their daily life for treatment of various kinds of diseases 
(Mulholland, 2005). The World Health Organisation (WHO) has assessed that >80% 
of the people in developing countries rely on herbal medicine for their medicinal uses 
(Gao & Ke, 2005)  In modern treatment of cancer, plants have been used widely to 
enhance the immune response as well as to diminish side effects of conventional 
treatments (Kathleen N., 2001).  
 
Anti-cancer activity by plant products is mostly brought about by induction of 
programmed cell death or by inhibition or stimulation of certain cellular pathways 
involved in cell proliferation or death. Programmed cell death (PCD) which is known 
 2 
 
to be induced by some of the plant extracts against some types of cells is an 
important mechanism by which cells maintain their homeostasis and remove dead 
cells (Schwartzman and Cidlowski, 1993). Three types of cell death mechanisms are 
reported. These include type I PCD; apoptosis, Type II PCD; autophagy and 
nonlysosomal cell disintegration or necrosis. These act by different mechanisms. 
Compared to necrosis, PCD has attracted more attention as the cell death mechanism 
does not cause inflammation to neighboring cells. Apoptosis is associated with 
characteristic changes such as membrane blebbing due to changes in membrane 
permeability, chromatin condensation and nuclear fragmentation, which are 
considered the hallmarks of apoptosis. The cell death caused by this mechanism only 
involves the particular cell (Bold et al., 1997). The decision of the cells to undergo  
apoptosis or autophagy is decided mainly by the functional status of caspase-3 (Fazi 
et al., 2008).  
 
Autophagy (Greek auto=self; phagy=to eat) is recognized as the type II mechanism 
of programmed cell death in eukaryotes. Even though described as early as forty 
years ago (Ericsson, 1969), the mechanisms involved in this mode of cell death has 
attracted attention mainly in the last decade. It occurs at a small level in all cells to 
maintain cellular homeostasis (eg; cytoplasmic and organelle turnover). Autophagy 
involves formation of double membrane vesicles in the cytosol. These vesicles trap 
materials programmed for degradation (Uchiyama et al., 2008; Levine and Yuan, 
2005), damaged organelles and also other organelles in times of nutrient depletion. 
The nutrients recycled from the degrading organelles are used for survival of the 
cells for short periods of time. During nutrient deprivation, developmental transitions, 
oxidative stress, infection and other stresses, this process is up regulated, mainly as a 
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pro-survival mechanism (Cuervo, 2004; Ravikumar et al., 2009). The vesicles 
formed fuse with the lysosomes to degrade the trapped material. Autophagic 
regulation mainly consists of two mechanisms, namely, the mechanism to shut down 
autophagy during nutritional abundance and the mechanism to turn on autophagy 
during stress. In cancer cells, autophagy acts as a double edged sword. In the earlier 
stages of cancer cell growth, autophagic mechanisms are inhibited to allow the 
growth of the cells while in the later stages, the cells inside the hypoxic regions turn 
on autophagy for survival (Cuervo, 2004). In yeast, during nutrient deprivation, the 
cells adopt autophagy and eventually die because of the excessive self-consumption 
and bioenergetic failure. However, if the nutrients are available anytime before the 
death of the cell, the cells retain viability and return to its normal state (Levine and 
Yuan, 2005) suggesting that autophagy could be a mechanism cells use to hibernate 
during nutrient deprivation.  
 
Autophagy is of importance in cancer stem cells and cancer cells resistant to 
chemotherapy. In cells that cannot die due to defects in the apoptotic pathway, as 
seen in many cancers, the autophagic mechanism is activated (Cuervo, 2004). 
Activation of autophagy suppresses apoptosis, thereby protecting some cells from the 
anti-cancer treatments while some cells, especially those in which the apoptotic 
mechanism is defective, undergo cell death following cancer therapy (Kondo et al., 
2005; Codogno and Meijer, 2005). Tamoxifen is reported to activate either 
autophagy or apoptosis or both in breast cancer cells (Bursch et al., 1996). A number 
of compounds such as tamoxifen, Temozolomide, sodium butyrate and 
Suberoylanilide hydroxamic acid (SAHA), Arsenic trioxide, Rapamycin and 
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treatment such as gamma radiation and hyperthermia induce autophagy in cancer 
cells (Brian et al., 2001).  
 
Eupatorium odoratum and Euphorbia hirta used in this study posses unique anti-
microbial and other medicinal properties as reported in literature (Redo et al., 2006). 
Traditionally, white latex of E. hirta plant is widely used to remove warts and tumors 
(Qing et al., 2008). The crude extract from this plant has been reported to 
demonstrate potent cytotoxic effects towards several cell lines. For instance, crude 
methanolic extracts of E. hirta showed anti-proliferative effects towards human 
epithelioma of larynx (Hep-2) in vitro (Raja, 2011). Besides, aqueous extract also 
showed reduction in prostaglandins I, E and D, thereby increasing tumour growth 
(Wang & Dubois, 2006). As for E. odoratum, it is traditionally used as a wound 
healing agent. Compounds from this plant include those with strong anti-cancer 
properties such as quercetin, eupalinin and luteolin (Bose et al., 1973, Suksamrarn et 
al., 2004; Yuan et al., 2005). In vitro study reports cytotoxic activity of extracts from 
leaves of this plant on lung cancer cells (NCI-H187) (Suksamrarn et al., 2004). 
Eventhough anti cancer activities of these plants have been reported, very few reports 
are available on the mechanism of cell death induced by the crude extracts especially 
on caspase-3 independent cell lines. In addition, the relevance of these plants in 
treating various kinds of microbial diseases and cancers in traditional medicine 
provides evidence for these plants to be developed as new chemotherapeutic drugs. 
Thus, the results from this study can be used as preliminary data for development of 
new anti cancer drugs from these plants targeting on the specific cell death 
mechanism.  
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Aim and objectives of the study 
 
This study was designed with the aim of evaluating the cytotoxic potential of            
E. odoratum and E. hirta on breast, cervix and ovarian cancer cells, as well as to 
identify the mechanism of cell death by the extracts.  
 
The specific objectives of this study were: 
1. To evaluate the cytotoxicity profile of the different extracts from E. odoratum 
and E. hirta on MCF-7, CaOV-3, Hela and Vero cell lines by MTT cytotoxicity 
assay. 
2. To determine the mechanism of cell death induced by potent plant extracts by 
morphological observation, DNA laddering, and expression of proteins 
involved during apoptosis and autophagy by immunocytochemistry staining. 
3. To determine the effect of the potent extract on cell cycle phases using flow 
cytometry analysis. 
4. To assess if there is any pro-proliferative effects for these extracts which is of 
importance in their use as drugs.  
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CHAPTER 2 - LITERATURE REVIEW 
 
This literature review encompasses descriptions of the (1) characteristics, and 
worldwide and Malaysian incidence of cancer in relation to the cell lines used in this 
study, (2) current treatment modalities and their drawbacks, (3) plants as anticancer 
agents, (5) modes of cell death by plant extracts and (6) characteristics and 
importance of the plants used in this study.  
2.1 Cancer-A life threatening disease 
The word ‘cancer’ refers to diseases that exhibit two characteristics in common: (1) 
an uncontrolled growth of cells and (2) the ability to invade and damage normal 
tissues locally or at distant sites in the body. The body is made up of large number of 
cells and has certain norms of behavior in order to maintain homeostasis (Jameson, 
2002). The normal cells show the characteristics of polarity, adhesion to the 
basement membrane, definite nuclear cytoplasmic ratio, transition from basal cell to 
differentiated cells, cell-cell contact, display of territorial limits, controlled and 
regulated growth, and controlled death or senescence in a programmed manner. 
However, at times, there is a disruption of this balance when the cells show abnormal 
growth signals, insensitivity to growth-inhibitory signals, evasion of apoptosis, loss 
of contact inhibition (Hanahan, 2000), ability to invade adjacent tissues and 
metastasize to distant tissues, immune escape, immortality, defects in DNA repair 
and sustained angiogenesis. 
 
Cancer is considered a genetic disease. It occurs when the deoxyribonucleic acid 
(DNA) present in a gene is altered by external or internal agents.  In such a situation, 
the gene can no longer instruct the cells to behave in the normal manner (Hanahan, 
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2000) and often results in cancer growth. The causes for DNA within a gene to be 
altered, recombine incorrectly or to mutate are multifold. The causative factor may 
be environmental as in the case of UV radiation from sunlight, exposure to chemicals 
used in industries and agriculture or infectious agents such as viruses and bacteria. 
Endogenous factors such as free radicals produced during metabolism or due to 
inheritance of susceptible mutations also cause mutations. Cell division and cell 
death are regulated by a network of proteins which are products of cellular genes. 
Alterations in these proteins by the cellular environment or damaging agents can lead 
to the disruption of the balance and cause uncontrolled division and accumulation of 
cells (Hanahan, 2000)  
 
Malignant transformation is thought to be the result of the accumulation of genetic 
defects (Pavan et al., 2008) and involve a multistep progression in involving 
oncogenes, tumor suppressor genes, DNA damage repairing genes and genes 
involved in cell death. Damage in any of these can lead to cancer formation. 
Literature show that plants and their products are capable of reducing or eliminating 
many of these effects and hence are worth evaluating for their efficacy as drugs 
(Sultana et al., 1995).  
2.1.1 The cancer burden 
Cancer occupies number one position as the leading cause of death worldwide.  It  
accounted for 12.7 million cancer cases and 7.6 million deaths reported in 2008 
(Figure 1.1) (Ferlay et al., 2008). Of these, 56% of the cases and 64% of the deaths 
were reported from the developing countries. The Asian countries contributed to 
45% of the cases and 12% of the deaths. The deaths due to cancer are projected to 
increase to over 11 million deaths by 2030 (Colin & Dejan, 2006). 
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According to the Globocan report 2008, South-Eastern Asia contributed for about 
142 cancer cases per 100, 000 populations in 2008. Lung cancer was reported to be 
the leading cancer (14%), followed by breast (12%), liver (10%) and colorectal 
cancers (9%) (Globocan, 2008).  
 
In peninsular Malaysia 70, 000 new cancer cases were diagnosed among Malaysians 
between 2003-2005. According to National Cancer Registry (NCR) Malaysia, 43.7% 
(29, 596 cases) cases were among males and 56.3% (38, 196 cases) among females. 
The most common cancers reported during this period were breast cancers (18%), 
large bowel cancers (11.9%) and lung cancers (7.4%) (Ferlay et al., 2008). Hence it 
is imperative that novel chemotherapeutics are discovered in order to reduce the 
burden of this disease both in Malaysia and worldwide. 
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Picture source : http://info.cancerresearchuk.org/cancerstats/  
Figure 2.1: Figure showing the prevalence of cancer cases worldwide in 2008.  
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2.1.2 Current treatment modalities and drawbacks 
Managing and treating of cancer can be done in various modalities targeted to cure, 
control the growth and prevent it from metastasizing. The treatment may be curative 
or palliative. The conventional therapies used to treat cancer that we are all familiar 
with are chemotherapy, radiation therapy and surgery depending on the location, 
grade of the tumor and stage of the disease. Modern therapy using mediators, 
complimentary medicine and plant products are gaining momentum. 
 
Chemotherapy is a systemic treatment using chemicals as drugs (Giani, 1976). The 
main goal of chemotherapy includes the total destruction of the cancerous cells and 
controls the disease from progressing. In advanced stages, it is also used to relieve 
the symptoms caused by cancer. Cisplatin is a commercially available anti-cancer 
drug used for treatment of cancers of epithelial origin including those of lung, 
stomach, ovary, bladder (MacMillan, 2010). Tamoxifen is commonly used for 
treatment of estrogen receptor positive breast cancers.  
 
Modern cancer therapies include use of bio-mediators such as angiogenesis inhibitors, 
targeted therapy using monoclonal antibodies, small molecules such as receptor 
inhibitors, small peptides used for homing of drugs, immunotherapy using immune 
mediators and other therapies such as photodynamic therapy, bone marrow 
transplantation, gene therapy, laser therapy, and also bacterial preparations and plant 
products. 
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In spite of millions of dollars spent on improving cancer therapeutics, it is 
disheartening to note that the overall survival rate for all cancers combined increased 
slightly from 49.3% in 1974-76 to 53.9% in 1983-1990. The old adage about cancer 
which says “hopefully the cancer won't kill you before the cancer cure does” is true 
to an extent, because, in conventional cancer therapy, the body is bombarded with 
toxic agents such as drugs and radiation. Even though the attack is directed against 
the cancer cells, the normal cells are also affected adversely, especially the immune 
system. This makes the elimination of the cancer cells less efficient. Besides this, the 
conventional treatments speak in terms of 5 year and 10 year survival rates which are 
transient improvements in the life span, often compromising on the quality of life 
(Conventional Cancer Treatments, 2011). Uncomfortable episodes of nausea, 
gastrointestinal problems, anemia, leucopenia, bleeding, general malaise, mental 
impairment (“chemo-brain”), hair loss, depression, somnolence, cognitive 
abnormalities, fatigue, loss of platelets, pain, irritation, fibrosis, secondary tumours, 
morbidity, increased risk of heart disease etc. are usually observed in the patients on 
conventional therapy (Giordano & Hortobagyi, 2007; Harbeck et al., 2011; Jones, 
2011; Wefel et al., 2001; Soussain et al., 2009; Sood et al., 2006; Abramowski, 
2010).  Furthermore, it is not possible to kill every cancer cell by the conventional 
treatments, a fact known by all oncologists. The importance of a fully functional 
immune system is very well recognized in the modern times and cancer is very often 
referred to as “failure of the immune system”. Drug resistance is another major 
hurdle in the removal of cancer cells by chemotherapy (Chung & Pascale, 2004). So 
the need of the moment is a therapeutic system which makes sure that there is no 
uncomfortable side effects to the patients and retains the integrity of the immune 
system to see that all the cancer cells in the host are killed following their reduction 
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by conventional therapeutic modalities. Plants are reported to act by targeting 
multiple pathways and increasing the immune status of the body (Christiane et al., 
1993). Hence it is expected that plants will be able to control cancers in a better way 
when compared to the conventional treatments.  
2.2 Anti-cancer substances from natural products 
Nature is a rich source of therapeutic compounds with millions of species of plants, 
animals, marine organisms and microorganisms and natural chemical structure types 
resulting from nature’s combinational chemistry efforts. In the words of Rudyard 
Kipling (1910), British Nobel Laureate “Anything green that grew out of the mould 
was an excellent herb to our fathers of old.” Kipling and Aristotle (1910) have righty 
put it as “Nature does nothing without purpose or uselessly.”  
 
A study on crude extracts is crucial in order to screen anti cancer properties of the 
plant in the initial stages of new chemotherapeutic development. This is based on 
evidence from studies on crude extracts from many plants. As for example, the study 
done by Bibi et al. (2011) observed anti-tumor effects of crude methanolic extract 
from Aster thomsonii plant against H157 and HT144 cancer cell lines in-vitro. In 
addition, methanol and n-hexane crude aqueous extracts of Inula viscosa showed 
cytotoxic effects towards MCF-7 and Hep-2 cancer cell lines in-vitro (Wamidh et al., 
2009). Crude extracts of seeds and leaves of neem plant have showed potent anti-
tumour activity against Ehrlich ascites carcinoma cells (EACC) (Hassan et al., 2010). 
 
Cragg and Newman (2006) has listed down compounds that originated from plants 
which are currently used as anti-cancer agents. These include camptothecin, 
tototecan, innotecan, taxol, docetaxel, vinblastine (VLB), vincristine (VCR), 
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teniposide, etoposide, podophyllotoxin, elliptinium and homoharringtonine. VLB and 
VCR are vinca alkaloids which are isolated from Catharanthus roseus. Clinically, it 
is used to treat leukemias, lymphomas, cancers of the breast and lung, and Kaposi’s 
sarcoma. VCR is effective in treating lymphomas and particularly effective in acute 
lymphocytic leukemia during childhood (Sriram & Yogeeswari, 2010). Etoposide 
and etinoposide which are isolated from Podophyllum peltatum (American 
mandrakes) are now commonly used clinically for treatment of lymphomas and 
bronchial cancers and also testicular cancers (Doo et al., 2010). Paclitaxel or taxol 
isolated from Taxus brevifolia is widely used for treatment of cancers of the breast, 
ovary and non-small lung cancer (NSCLC) besides showing effectiveness against 
Kaposi’s sarcoma (Ettinger, 1993). Camphothecin, another compound from 
Camptotheca acuminate is used widely in small cell lung cancer (SCLC) treatment. 
Homoharringtonine, isolated from Cephalotaxus harringtonia, is successfully used in 
China for acute myelogenous leukemia and chronic myelogenous leukemia treatment. 
All these compounds have been discovered after the initial crude extracts being 
evaluated for their activities which stresses on the importance of evaluation of crude 
extracts.  
 
Many other compounds form plants are still in research as anti-cancer drug 
candidates. These include Calanolide A and B, isolated from C.lanigerum and 
C.teysmannii which are indigenous to Sarawak, Malaysia (Kaysmann et al., 1992).  
 
2.3 Traditional medicines in cancer therapy 
Humans began using plant alkaloids as pharmaceuticals as early as 3000 B.C. 
(Roberts and Wink, 1998). The medicinal benefits of herbs are extensively quoted 
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throughout history in the Vedas, Bible, Koran and other texts and the treatment using 
these herbs have come to be known as herbalism or herbal medicine. Herbalism is a 
traditional folk medicine based on the use of plant components (Anon, 2011). 
 
Indigenous people in Africa use up to 4000 taxas of plant for medicinal purposes 
(Mulholland, 2005). The medicines from plants are used as tinctures, teas, poultices, 
powders and other herbal formulations by these people (Samuelsson, 1992). The 
specific combination of the plants and the methods of preparation and application for 
the particular ailments were mostly passed down to the next generations orally. No 
written documents were maintained in most instances. In the more recent times, 
some documentation became available in the form of the Hindu scriptures (6000 
years ago) and Chinese text books (2700 B.C.). The Sumerians practiced herbal 
medicine around 5000 years back and early Egyptian medicine practices were 
documented in 1000 B.C. It was the Greek physician, Pedanius Dioscorides, in the 
first century A.D, who first compiled the European treatise on the properties and uses 
of medicinal plants, De Materia Medica. The Greek contributed in a big way to the 
documentation of the medicinal practices, as preserved in the writings of Hippocrates 
and the Greek book that founded the science of Botany, ‘Theophrastus Historia 
Plantarur’ written in the fourth century B.C. (Michael, 2010).  
 
However, it is only in the near recent periods that the importance of natural products 
was recognized and the use of plants involving isolation of active compounds from 
plants was attempted. The isolation of morphine from opium in the early 19th century 
was one of the first examples (Kinghorn et al., 2003; Samuelsson, 1992). 
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2.4 Biological activities of natural products: Anti-tumor point of view 
Darwin’s theory of evolution states ‘survival of the fittest’ as one of the main 
strategies of evolution. In accordance with this, plant species that have evolved the 
capacity to defend themselves from potential predators and to inhibit other plants 
competing for space have been selected for (natural selection) survival (Mans et al., 
2000). To survive in nature, in the face of the stiff competition, the plant has evolved 
sophisticated defense mechanisms including an arsenal of toxic substances, such as 
terpenes and alkaloids. A survival mechanism adopted by the plants is production of 
toxic substances that can kill the predator organisms or inhibit the growth of other 
plants. This compound could also be effective in killing human cells and hence act as 
anti cancer compounds. This is usually brought about by secondary metabolites 
known as anti-herbivory that can influence the behaviour, growth and survival of 
organisms and plants. The anti-herbivory compounds can be classified into three sub-
groups: The alkaloids, terpenoids and phenolics (Carmona et al., 2011). Alkaloids, 
activate or inhibit enzymes, bind to nucleic acids and inhibit protein synthesis and 
affect a diversity of metabolic systems in humans and animals (Roberts and Wink, 
1998). Terpenoids and phenolic compounds have a diversity of functions in humans 
and animals. Similar to these compounds, a number of compounds have been 
identified in the recent times which are of help in combating cancer cells using 
diverse mechanisms. Traditional practitioners exploited these natural defense 
mechanisms of the plants to treat various kinds of diseases including cancer. Taking 
cues from these practices, modern medicine has developed several medicines for 
cancer treatment from natural products. The most significant examples are the 
development of vinca alkaloid family isolated from the periwinkle C. roseus, found 
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in the rain forests of Madagascar and taxols from the bark and leaves of Taxus 
brevifolia (Noble, 1990). 
 
Acronychia baueri, a plant of Australian origin which is used for blood cancer 
treatment contains alkaloid acronycine which is responsible for its activity. Allium 
sativum was used by the Japanese to increase immunity in cancer patients which 
indirectly prevents cancer progression. Similar effects were discovered in Astragalus 
membranaceus root. Aloe vera juice and Althea officinalis were used for treatment of 
gastro-intestinal tract and skin cancers. In Malaysia, Andrographis paniculata was 
used in diabetic patient as well as in cancer treatment. A study by Ajaya et al. (2004) 
revealed the anticancer activity of this plant against HT-29 (colon cancer) cells, 
attributed to the presence of andrographolide present in the extract. Researchers also 
observed control of growth of ovarian cancers when treated with Curcuma zedoaria 
as well as Cratageus cuneata (Ajaya et al., 2004). Besides being used directly to 
reduce cancer cell progression, plants are also used as complementary medicine in 
conjunction with standard drugs. This was found to be helpful in reducing side 
effects of these drugs. For example, Chinese herbal medicine (CHM) when combined 
with chemotherapy was observed to raise the efficacy level as well as reduce 
chemotherapy toxicity (Zhou et al., 2008). 
 
Apart from giving promising effects when combined with commercially available 
drugs, practitioners also combine several types of plants and mix it to produce tonics, 
ready for consumption. Triphala (Ayurvedic formulation), used in India for cancer 
treatment was shown to have anti-cancer effects against breast adenocarcinoma cells 
(MCF-7) in vitro (Sandhya et al., 2006). 
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Active compounds which demostrate anti-cancer activity have been screened by 
many researchers all over the world. For instance, studies on C.roseus revealed that 
its alkaloid compound, vincristine and vinblastine can retard childhood leukemia and 
Hodgkin’s disease progression. Recent studies of extracts from Trailliaedoxa gracilis 
showed anti-proliferative effects against small intestine (SI) neuroendocrine tumors 
(NETs) without affecting normal fibroblasts in vitro. The mechanism of cell death 
suggested was apoptotic cell death (Svejda et al., 2010). A study by Kan (2008) 
demonstrated anti-proliferative effects of phthalides isolated from Angelica sinensis 
on colon cancer. In addition, the extracts also showed synergistic effects of this 
compound against colon cancer cell lines when combined with chemotherapy. 
Results from South-western Nigeria studies in plants commonly used in cancer 
treatment by old folks proved the cytotoxic effects of some of the extracts against 
cancer cell lines tested (Ashidi et al., 2010). A study conducted by Kong et al. (2010) 
revealed that Glehnia littoralis suppressed proliferation and MMP expression in 
HT1080 cells in vitro (Kong et al., 2010). In the study, glucopyranosides, 
furanocoumarins and polyacetylenic alcohols were isolated and found to be the 
functional compounds. The polyacetylenic alcohols showed highest inhibitory 
activity against human cancer cell lines (Kong et al., 2010). 
 
2.5 Mechanism of anti-cancer activity of natural products 
Plant extracts are known to induce cell death through different mechanisms. The cell 
death mechanisms are activated, most often to remove unwanted, dead or senescent 
cells or cells damaged beyond repair. At times, this is also used as a survival 
mechanism in response to stress such as nutritional depletion or exposure to toxic 
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materials. The persistence of the stress exhausts the cell of its survival mechanism 
and leads to cell death. Cytotoxic effects of plant extracts can induce different kinds 
of cell death mechanism namely; necrosis and programmed cell death (PCD). 
However, programmed cell death is more favorable to be studied as it does not cause 
damage the neighboring cells (Susan, 2007). PCD is a normal and basic biological 
process which has important roles during human development, tissue homeostasis 
and elimination of damaged cells. Two different types of PCD are (1) apoptosis and 
(2) autophagy.  
2.5.1 Programmed cell death Type I- Apoptosis  
Apoptosis is an active form of cell death. During apoptosis, the decision to undergo 
cell death is made when the cells receive signal from outside (external) or from 
inside the cells (internal). Examples of external or extracellular signals include toxins, 
hormones, growth factor, nitric oxide or cytokines. Extrinsic pathway is activated by 
binding of tumor necrosis factor (TNF) to the death receptor embedded in the lipid 
bilayer of the cell. The binding induces recruitment of Fas-associated death domain 
(FADD) adaptor proteins which have death effect domain (DED). DED then recruits 
similar DED which is expressed by pro-caspase-8/10 and convert it to the active 
caspase-8/10. Active caspase-8 then activates pro-caspase-3 into active caspase-3. 
Activation of caspase-3 lead to the release of caspase activated DNase (CAD) from 
its inactive ICAD. Subsequently, DNA fragmentation result in chopping of DNA 
strand into multiple fragments ranging from 180-200 bp and multiples thereof in size. 
 
Compared to extrinsic pathways of cell death, intrinsic pathways for cell death are 
activated in response to free radicals, hypoxia, radiation, DNA damage or activated 
oncogenes. Normally, BCl-2, an anti-apoptotic protein, exists as a homodimer on the 
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mitochondrial surface while Bad exist as freeform inside the cytosol which prevents 
cell death. Upon receiving apoptotic signals, Bad is phosphorylated and translocated 
to the mitochondrial membrane and interact with BCl-2 protein. This results in 
translocation of Bax protein which binds with the mitochondrial surface. Interactions 
of this pro-apoptotic protein with the surface of mitochondrial membrane eventually 
lead to the formation of pores which allow cytochrome-c and pro-caspase-3 from 
intermembrane space to be released into cytoplasm. Free cytochrome-c interacts with 
Apaf-1 protein which recruits pro-caspase-9 to form a complex with cytochrome-c 
and apaf-1 called apoptosome. Activation of caspase-9 will induce activation of 
caspase-3, finally causing cell death. Figure 2.2 shows intrinsic and extrinsic 
pathways of cell death.  
 
Source: (Ghavami et al., 2009) 
Figure 2.2: Figure showing intrinsic and extrinsic pathways of 
apoptotic cell death induced in cells in response to 
external and internal signals.  
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Apoptosis is characterized by distinctive hallmarks such as cell shrinkage, plasma 
and nuclear membrane blebbing, organelle relocalization and compaction, chromatin 
condensation and finally the formation of particles containing intracellular material 
also known as apoptotic bodies (Bold et al., 1997). 
 
Apoptosis induction by extracts from plants has been reported. Japanese traditional 
medicine; Sho-saiko, which is used in treatment of chronic liver disease showed 
inhibition of growth of hepatocellular carcinoma cell lines in vitro and killed cells by 
promoting apoptosis and causing cell cycle arrest (Yano et al., 1994). Mistletoe 
extracts induced apoptosis in B cell hybridomas, human leukemic monocyte 
lymphoma (U937) and mouse lymphoblast-like mastocytoma cell line (P815) in vitro. 
The extracts caused nucleosomal fragmentation which is evidenced as DNA 
fragments with approximate size of 180-200 bp (Janssen et al., 1993). The 
procyanidins extracted from grapes was instrumental in releasing cytochrome-c from 
intermembrane space of mitochondria leading to caspase pathway activation 
(Agarwal et al., 2002). The extracts from Bituminaria bituminosa and Toona sinensis 
are reported to induce apoptosis in human colon cancer (Maurich et al., 2006) and 
human pre-myelocytic leukemia (HL-60) cells respectively. 
 
Current chemotherapeutic drugs which induce apoptosis include staurosporine and 
bleomycin. Both of them execute different pathways of cell death. The apoptotic 
pathway is often deregulated in cancers which result in the cancer cell developing 
resistance to therapy. 
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2.5.2 Programmed cell death Type II- Autophagy 
Autophagy is classified as Type II programmed cell death to aid in the removal of 
damaged organelles.  Autophagy acts as a survival mechanism in response to 
starvation, especially in vital organs, where depletion of nutrient is not permissible. 
However in disease such as cancer, expression of proteins related to autophagic 
mechanism is expressed to aid survivorship of tumor cells. Inducers of autophagy 
include starvation, hypoxia and microbial infection. In situations where apoptosis is 
down regulated, autophagy is induced (Buytaert et al., 2007; Hetz, 2007; Lefranc et 
al., 2007; Moretti et al., 2007; Hu and Xuan, 2008). 
 
Based on the mechanism used to deliver the organelles to lysosomes, autophagic cell 
death can be divided into three types; (1) macroautophagy, (2) microautophagy and 
(3) chaperon mediated autophagy. The most well explained mechanism of autophagy 
is macroautophagy. Isolated membrane engulfs old or nearly dead organelles to form 
autophagosomes which later fuse with late endosome or multivesicular body to form 
another complex named as amphisome. With the aid of proteins encoded by genes 
such as Atg12, Atg7, Atg10, Atg5, Atg6, Atg16, Atg4, Atg8, Atg7 and Atg3, 
amphisomes fuse with lysosomes to form autolysosomes. The fusion of amphisomes 
to form autolysosomes creates double membrane vacuoles which are visible under 
microscopic observation. It appears as orange punctuated particles in fluorescence 
microscopy. Generation of autophagic vacuoles have been suggested to be indicators 
of the strength of toxic insult (Bursch et al., 2008). The cells try to survive in the face 
of the toxic insults by removal of the damaged organelles and toxic agents. However, 
in situation of excessive damage, the effort of the cells to survive gets exhausted and 
they undergo autophagic cell death (Bursch et al., 2008). This process is also 
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controlled by light-chain microtubule associated protein (LC3-A/B). Besides, Beclin 
proteins are involved during the formation and maturation of autophagosomes. The 
initiation of autophagy is also controlled by mammalian target of rapamycin (mTOR). 
Autophagic mechanism of cell death and genes involved are shown in Figure 2.3.  
 
 
Source: (Maiuri et al., 2007) 
Figure 2.3: Figure showing different stages, regulatory genes and 
proteins during autophagic mechanism of cell death.  
During induction, mTOR is activated and isolation of membrane is 
controlled by Beclin-1 protein. During organelles retrieval, the process 
is controlled by Atg family protein. Formation of autophagosome is 
preceded by fusion with lysosomes which lead to breakdown and 
degradation of organelles. 
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Studies on the mechanism of cell death by drugs show that many of the 
chemotherapy drugs use autophagy as the cell killing mechanism. Research by 
Ertmer et al. (2007) demonstrated the induction of autophagy by imatinib in chronic 
myelogenous leukemia (CML) (Ertmer et al., 2007). Resveratrol has been reported to 
induce autophagocytosis in ovarian cancer cells (Opipari et al., 2004), temozolomide 
and camptothecin (CPT) induce autophagy in glioblastoma (Lefranc and Kiss, 2006) 
and breast cancer cells (Motyl et al., 2006). In addition, tamoxifen and epirubicin 
induce autophagy in breast tumor cells (Bilir et al., 2000). Plant extracts also have 
shown potential to induce autophagic cell death. Treatment with tamoxifen induces 
autophagy in MCF-7 breast cancer cells in a caspase-3 independent manner. Table 
2.1 show examples of plants which induce autophagy and their target pathways.  
 
Table 2.1:Example of plants that induce autophagic cell death. 
Plant name  Cancer cells affected  Target pathway 
Phillyrea 
latifolia 
Hepatocellular 
carcinoma 
 
Up-regulation of eIF2-α, down-
regulation of mTOR and BCl-2 
(Longo et al., 2008) 
Solanum nigrum HepG2 cells 
 
Increase expression of p-JNK and Bax, 
cytochrome-c, caspase activation 
(Lin et al., 2007) 
Areca nut Oral cancer cells 
 
Activation of p38, MKP-1, HIF-1α 
(Lu et al., 2010) 
Glycyrrhiza 
glabra  
Human LNCaP prostate 
cancer cells 
 
Suppression of BCL-2 and mTOR 
pathway 
(Yo et al., 2009) 
Sutherlandia 
frutescens  
Breast cancer cells 
 
Activation of LC3 protein 
(Stander et al., 2009) 
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2.5.3 Necrosis 
Another mechanism of cell death by plant products which differs from Type I and 
Type II PCD is necrosis. It is defined as a type of cell death which lacks the features 
of apoptosis and autophagy. Necrotic cell death often induces local inflammation via 
induction of innate immune system (Golstein and Kroemer, 2007). As necrosis 
induce inflammation in the neighborhood, the mechanism has not gained importance 
as an indicator in screening of potential anticancer agents. Screening for anticancer 
activity of plants necessitates that the plant products do not induce necrosis.  
 
In necrosis, organelles such as mitochondria dilate and ribosomes dissociate from 
endoplasmic reticulum. Later, nucleus disintegrates and in some cells, chromatin 
condensation occurs (not all cells). The nucleus is digested by enzymes, resulting in 
digested DNA which appears as DNA smear in agarose gel electrophoresis. 
 
Necrotic cells can be detected easily as membrane of necrotic cells become more 
permeable and allows small charged molecules to enter into the cell that does not 
normally enter the cells. Common method of detection is via morphological analysis 
and via propidium iodide staining. In this method, binding of the dye to RNA or 
DNA result in increase of the PI fluorescence making them suitable for imaging 
analysis. Other methods of detection involve using of Hoechst stains, using N-
hydroxysuccinimidyl biotin (NHS-Biotin) which is a permeable dye that stain dead 
cells, but not viable cells which have intact impermeable membrane (Ziegler and 
Groscurth, 2004). 
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2.6 Plants used in this study 
2.6.1 E. odoratum (EO) 
Eupatorium odoratum L. is a member of the asteraceae family and is locally known 
as bitter bush, Siam weed, baby tea, cariaquillo, Santa Maria, and pokok kapal 
terbang. Located mostly at the roadside, riverbank or wet area, it is a common native 
shrub in Florida and South Africa and in tropical countries including Malaysia. This 
free standing shrub can reach up to 1m tall. Its root is fine lateral and yellowish in 
color. The leaves are positioned opposite each other and have deltoid to oval-
lanciolate shape. The leaf margins are dentate with a long pointed tip. Flowers of this 
plant are lavender, pink, white or blue in color. Figure 2.4 shows E. odoratum plant 
in its natural environment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: E. odoratum L. plant. 
20mm 
